Novartis Names Joe Jimenez CEO to Replace Vasella (Update1)

[guest]

Novartis AG named Joe Jimenez, head of the company’s pharmaceuticals division, to take over as chief executive officer from Daniel Vasella effective Feb. 1.


More...

Toggle signature
||||| Mentor Group Access Now! |||||